Literature DB >> 28947708

Fitness-compensatory mutations facilitate the spread of drug-resistant F15/LAM4/KZN and F28 Mycobacterium tuberculosis strains in KwaZulu-Natal, South Africa.

Charissa C Naidoo1, Manormoney Pillay.   

Abstract

While the acquisition of drug resistance is often accompanied by fitness costs, Mycobacterium tuberculosis has developed mechanisms to overcome these costs in the form of compensatory mutations. In an attempt to dissect strain-specific differences in biological fitness, 10 M. tuberculosis genomes, representing F15/LAM4/KZN, Beijing, F11 and F28 genotypes were sequenced on the Illumina MiSeq platform. Drug-susceptible F15/LAM4/KZN strains differed by 43 SNPs, demonstrating that heterogeneity exists even among closely-related strains. We found unique, nonsynonymous single-nucleotide polymorphisms (SNPs) in the sigA and grcC1 genes of multidrug resistant (MDR) and XDR F15/LAM4/KZN strains, respectively. The F28 MDR strain harboured a novel ubiA mutation in combination with its embB M306I mutation, which may be related to ethambutol resistance. In addition, it possessed a low-frequency rpoC mutation, suggesting that this strain was in the process of developing compensation. In contrast, no compensatory mutations were identified in Beijing and F11 MDR strains, corroborating its low in vitro fitness. Clinical strains also harboured unique SNPs in a number of important genes associated with virulence, highlighting the need for future studies which examine the correlation of genetic variations with phenotypic diversity. In summary, whole-genome sequencing revealed the presence of fitness-compensatory mutations in F15/LAM4/KZN and F28 genotypes which predominate in MDR and/or extensively drug resistant (XDR) forms in KwaZulu-Natal, South Africa.

Entities:  

Mesh:

Year:  2017        PMID: 28947708     DOI: 10.1007/s12041-017-0805-8

Source DB:  PubMed          Journal:  J Genet        ISSN: 0022-1333            Impact factor:   1.166


  47 in total

1.  Changing Mycobacterium tuberculosis population highlights clade-specific pathogenic characteristics.

Authors:  G D van der Spuy; K Kremer; S L Ndabambi; N Beyers; R Dunbar; B J Marais; P D van Helden; R M Warren
Journal:  Tuberculosis (Edinb)       Date:  2008-12-02       Impact factor: 3.131

2.  Effect of mutation and genetic background on drug resistance in Mycobacterium tuberculosis.

Authors:  Lukas Fenner; Matthias Egger; Thomas Bodmer; Ekkehardt Altpeter; Marcel Zwahlen; Katia Jaton; Gaby E Pfyffer; Sonia Borrell; Olivier Dubuis; Thomas Bruderer; Hans H Siegrist; Hansjakob Furrer; Alexandra Calmy; Jan Fehr; Jesica Mazza Stalder; Béatrice Ninet; Erik C Böttger; Sebastien Gagneux
Journal:  Antimicrob Agents Chemother       Date:  2012-04-02       Impact factor: 5.191

Review 3.  Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence.

Authors:  Issar Smith
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

4.  Putative compensatory mutations in the rpoC gene of rifampin-resistant Mycobacterium tuberculosis are associated with ongoing transmission.

Authors:  M de Vos; B Müller; S Borrell; P A Black; P D van Helden; R M Warren; S Gagneux; T C Victor
Journal:  Antimicrob Agents Chemother       Date:  2012-12-03       Impact factor: 5.191

5.  Effect of the efflux inhibitors 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-beta-naphthylamide on antimicrobial susceptibility and virulence factor production in Vibrio cholerae.

Authors:  Xiaowen R Bina; Julie A Philippart; James E Bina
Journal:  J Antimicrob Chemother       Date:  2008-11-14       Impact factor: 5.790

6.  Tracking a tuberculosis outbreak over 21 years: strain-specific single-nucleotide polymorphism typing combined with targeted whole-genome sequencing.

Authors:  David Stucki; Marie Ballif; Thomas Bodmer; Mireia Coscolla; Anne-Marie Maurer; Sara Droz; Christa Butz; Sonia Borrell; Christel Längle; Julia Feldmann; Hansjakob Furrer; Carlo Mordasini; Peter Helbling; Hans L Rieder; Matthias Egger; Sébastien Gagneux; Lukas Fenner
Journal:  J Infect Dis       Date:  2014-10-30       Impact factor: 5.226

7.  The non-clonality of drug resistance in Beijing-genotype isolates of Mycobacterium tuberculosis from the Western Cape of South Africa.

Authors:  Thomas R Ioerger; Yicheng Feng; Xiaohua Chen; Karen M Dobos; Thomas C Victor; Elizabeth M Streicher; Robin M Warren; Nicolaas C Gey van Pittius; Paul D Van Helden; James C Sacchettini
Journal:  BMC Genomics       Date:  2010-11-26       Impact factor: 3.969

8.  Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes.

Authors:  Iñaki Comas; Sonia Borrell; Andreas Roetzer; Graham Rose; Bijaya Malla; Midori Kato-Maeda; James Galagan; Stefan Niemann; Sebastien Gagneux
Journal:  Nat Genet       Date:  2011-12-18       Impact factor: 38.330

9.  Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum.

Authors:  Natalie J Garton; Simon J Waddell; Anna L Sherratt; Su-Min Lee; Rebecca J Smith; Claire Senner; Jason Hinds; Kumar Rajakumar; Richard A Adegbola; Gurdyal S Besra; Philip D Butcher; Michael R Barer
Journal:  PLoS Med       Date:  2008-04-01       Impact factor: 11.069

10.  Evolution and transmission of drug-resistant tuberculosis in a Russian population.

Authors:  Nicola Casali; Vladyslav Nikolayevskyy; Yanina Balabanova; Simon R Harris; Olga Ignatyeva; Irina Kontsevaya; Jukka Corander; Josephine Bryant; Julian Parkhill; Sergey Nejentsev; Rolf D Horstmann; Timothy Brown; Francis Drobniewski
Journal:  Nat Genet       Date:  2014-01-26       Impact factor: 38.330

View more
  3 in total

1.  Linking minimum inhibitory concentrations to whole genome sequence-predicted drug resistance in Mycobacterium tuberculosis strains from Romania.

Authors:  Carolien Ruesen; Anca Lelia Riza; Adriana Florescu; Lidya Chaidir; Cornelia Editoiu; Nicole Aalders; Dragos Nicolosu; Victor Grecu; Mihai Ioana; Reinout van Crevel; Jakko van Ingen
Journal:  Sci Rep       Date:  2018-06-26       Impact factor: 4.379

2.  Mutant RNA polymerase can reduce susceptibility to antibiotics via ppGpp-independent induction of a stringent-like response.

Authors:  Gerrit Brandis; Susanna Granström; Anna T Leber; Katrin Bartke; Linnéa Garoff; Sha Cao; Douglas L Huseby; Diarmaid Hughes
Journal:  J Antimicrob Chemother       Date:  2021-02-11       Impact factor: 5.790

3.  Transmission, distribution and drug resistance-conferring mutations of extensively drug-resistant tuberculosis in the Western Cape Province, South Africa.

Authors:  Selien Oostvogels; Serej D Ley; Tim H Heupink; Anzaan Dippenaar; Elizabeth M Streicher; Elise De Vos; Conor J Meehan; Keertan Dheda; Rob Warren; Annelies Van Rie
Journal:  Microb Genom       Date:  2022-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.